20275 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing heavy metals Iron group metal compounds
TREATING IRON DEFICIENCY WITH FERRIC CARBOXYMALTOSE
#2A significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7 and cell cycle arrest of colon cancer cell lines HCT-116 and SW- 480 via G0-G1
#3ORGANOMETALLIC COMPLEX, CONTROLLED-RELEASE MULTI-FUNCTIONAL DRUG, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE
#4METHOD OF TREATING CHRONIC KIDNEY DISEASE
#5FERRIC CITRATE DOSAGE FORMS
#6Significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7 and cell cycle arrest of colon cancer cell lines HCT-116 and SW- 480 via G0-G1
#7ARTIFICIAL OXYGEN CARRIER BLOOD PRODUCT
#8PHARMACEUTICAL COMPOSITION FOR SUPPRESSING TMPRSS2 EXPRESSION
#9PEDIATRIC FORMULATIONS OF FERRIC CITRATE
#10Treating iron deficiency with ferric carboxymaltose
#11USE OF FERRIC CITRATE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA
#12Treating iron deficiency with ferric carboxymaltose
#13USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
#14FORTIFIED MICRONUTRIENT SALT FORMULATIONS
#15METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE
#16Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
#17Prenatal Dosage Forms, Methods of Administration and Kits Thereof
#18ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR DELIVERING NITRIC OXIDE TO A PATIENT'S CIRCULATORY SYSTEM OR BRAIN
#19Methods for alleviating kidney disease and fibrosis of organ
#20COMPOUNDS FOR PREVENTING MIGRATION OF CANCER CELLS
#21AQUEOUS IRON CARBOHYDRATE COMPLEXES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM
#22BEVERAGE FORTIFIED WITH FERROUS BISGLYCINATE
#23Ferric Organic Compounds, Uses Thereof and Methods of Making Same
#24METHOD OF TREATING CHRONIC KIDNEY DISEASE
#25Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
#26INDUCTION OF ARTERIOGENESIS WITH AN NO (NITRIC OXIDE) DONOR
#27PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION
#28USE OF AN ORGANOMETALLIC COMPOUND AS A DNA-DEMETHYLATING AGENT
#29Composition comprising ferrous amino acid particles and method for treating or ameliorating pancreas-related disease using the same
#30Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
#31TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS
#32DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS
#33PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#34Treating iron deficiency with ferric carboxymaltose
#35Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
#36Method and means for diagnosing and treating allergy
#37COMPOSITION AND METHOD OF AN IRON SUPPLEMENT
#38Radioprotection, Radiomitigation and Radiorecovery
#39IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF
#40Aqueous iron carbohydrate complexes, their production and medicaments containing them
#41A STABLE ORAL PHARMACEUTICAL COMPOSITION OF FERRIC CITRATE
#42Aqueous iron carbohydrate complexes, their production and medicaments containing them
#43BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK
#44Biofilm inhibiting compositions enhancing weight gain in livestock
#45FERRIC CITRATE DOSAGE FORMS
#46Treating iron deficiency with ferric carboxymaltose
#47Chlorin-vitamin conjugates
#48FERRIC CITRATE DOSAGE FORMS
#49Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
#50ARTICLES OF MANUFACTURE AND METHODS OF TREATMENT FOR ANEMIA
#51Prophylactic or therapeutic agent for hyperaciive bladder
#52Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
#53ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
#54Method for Treating Liver Dysfunction
#55Sintered ferrous amino acid particles and use of the same against a virus
#56Thixotropic oxidized cellulose solutions and medical applications thereof
#57REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER
#58Use of ferrous amino acid chelate to treat infection by enteropathogen and to enhance growth performance
#59INJECTION COMPOSITION COMPRISING AN IRON DEXTRAN COMPLEX AND VITAMINS FOR PREVENTING AND TREATING ANEMIA
#60AQUEOUS IRON CARBOHYDRATE COMPLEXES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM
#61Sintered ferrous amino acid particles and use of the same against a virus
#62PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#63USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
#64Aqueous iron carbohydrate complexes, their production and medicaments containing them
#65Compositions and methods for treating and preventing venom related poisoning
#66Biofilm inhibiting compositions enhancing weight gain in livestock
#67Chlorin-vitamin conjugates
#68Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
#69Aqueous formulation containing 5-aminolevulinic acid or the like
#70PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF
#71REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER
#72FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#73Biofilm inhibiting compositions enhancing weight gain in livestock
#74Iron amino acid compounds, method for preparing iron amino acid compounds, compositions containing iron amino acid compounds, and uses thereof
#75Biofilm inhibiting compositions enhancing weight gain in livestock
#76ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
#77Antibacterial microelement chelates and the use thereof in animal feeds
#78Patches and Methods for the Transdermal Delivery of a Therapeutically Effective Amount of Iron
#79Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
#80Antimicrobial preparation and uses thereof
#81No-donors for the treatment of cerebrovascular vasospasms after brain hemorrhage
#82Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
#83METHOD FOR REVERSING, PREVENTING, DELAYING OR STABILIZING SOFT TISSUE CALCIFICATION
#84PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#85ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
#86Compositions and methods for treating and preventing venom related poisoning
#87PRODUCT BASED ON IRON BIS-GLYCINATE CHELATE AND ALGINIC ACID AND/OR WATER-SOLUBLE SALTS THEREOF, FORMULATIONS THEREOF, AND PHARMACEUTICAL USES THEREOF
#88Antimicrobial compounds and compositions, and uses thereof
#89Antimicrobial compounds and compositions, and uses thereof
#90Method of treating chronic kidney disease
#91Biofilm inhibiting compositions enhancing weight gain in livestock
#92PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND
#93Biofilm inhibiting compositions enhancing weight gain in livestock
#94IRON NICOTINATE COMPOSITION
#95USE OF FERRIC CITRATE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA
#96Method for reversing, preventing, delaying or stabilizing soft tissue calcification
#97Arsenoplatin anti-cancer agents
#98Treatment or prevention of anaemia in pregnant non-human mammals
#99Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics
#100Reduction of gastrointestinal tract colonisation by
#101Fortified micronutrient salt formulations
#102Induction of arteriogenesis with an NO (nitric oxide) donor
#103Metallocene derivatives with anticancer activity
#104COMPOSITION
#105Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
#106Compositions and methods for cancer therapy
#107Ferric organic compounds, uses thereof and methods of making same
#108Antimicrobial preparation and uses thereof
#109Arsenoplatin anti-cancer agents
#110USE OF COMPOSITION CONTAINING IRON (II) AMINO ACID CHELATE IN PREPARATION OF DRUG FOR AMELIORATING DIABETES
#111Thixotropic oxidized cellulose solutions and medical applications thereof
#112Method and means for diagnosing and treating allergy
#113Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#114Ferric citrate dosage forms
#115Metal-salen complex compound, local anesthetic and antineoplastic drug
#116Enhancer of survival of transplanted organ
#117Enhancer of survival of transplanted organ
#118FEED FOR LACTATING RUMINANTS
#119Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#120Agent for preventing and/or treating veisalgia
#121Antimicrobial compounds and compositions, and uses thereof
#122Methods and Compositions for Enhancing Iron Absorption
#123Magnetic nanoparticle composition and manufacturing method and use thereof
#124Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#125Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
#126Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
#127Resorbable oxidized cellulose embolization solution
#128METHOD OF TREATING IRON DEFICIENCY ANEMIA
#129Fortified micronutrient salt formulations
#130Antibacterial microelement chelates and the use thereof in animal feeds
#131USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
#132Method for cancer treatment
#133Reduction of gastrointestinal tract colonisation by campylobacter
#134Iron supplement
#135Agent for Preventing and/or Treating Veisalgia
#136Self-magnetic metal-salen complex compound
#137Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#138Anemia of cancer improving/prophylactic agent
#139Erythropoietin production-promoting agent
#140Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
#141Prophylactic agent for chronic kidney disease
#142Enhancer of survival of transplanted organ
#143Metal-salen complex compound responsive drug and intra-corporeal behavior control system for metal-salen complex compound
#144Iron supplement composition
#145USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
#146Actinomycete strain composition and its use
#147METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG
#148COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN
#149Prophylactic agent and/or therapeutic agent for sepsis
#150Composition and method for improving survival of bee colonies
#151Ferric organic compounds, uses thereof and methods of making same
#152Ferric organic compounds, uses thereof and methods of making same
#153Ferric organic compounds, uses thereof and methods of making same
#154USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
#155Exercise performance-increasing nutritional supplement and related methods and compositions
#156FERRIC CITRATE DOSAGE FORMS
#157Control of Blood Vessel Physiology To Treat Skin Disorders
#158Iron(II)-Containing A Treatments for Hyperphosphatemia
#159Oral iron deficiency therapy
#160Buffered Upper GI Absorption Promoter
#161Aqueous iron carbohydrate complexes, their production and medicaments containing them
#162METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION
#163Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#164Fluorochrome material and method for using the same
#165Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#166Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
#167Method for producing purified hematinic iron-saccharidic complex and product produced
#168Aqueous iron carbohydrate complexes, their production and medicaments containing them
#169PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF FERRIC IRON COMPOUNDS, AND METHODS OF USE THEREOF
#170PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELATABLE METAL COMPOUNDS, AND METAL-HDAC INHIBITOR CHELATE COMPLEXES
#171Ferric citrate dosage forms
#172Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
#173Metal ion nanoclusters
#174METHOD FOR TREATING PARKINSON'S DISEASE THROUGH REGULATING VDAC1 PROTEIN
#175Enhancing coagulation or reducing fibrinolysis
#176Auto magnetic metal salen complex compound
#177Treatment solution for treating wounds, in particular for liquid wound treatment
#178Treatment of retroviral reservoirs exploiting oxidative stress
#179Ferrate(VI)-containing compositions and methods of using ferrate(VI)
#180Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
#181Synthesis of high molecular weight iron-saccharidic complexes
#182Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
#183Dietary Supplement Compositions and Methods of Making and Using the Same
#184Dietary Supplement Compositions and Methods of Making and Using the Same
#185External preparation for skin
#186METHOD OF REVERSING, PREVENTING, DELAYING OR STABILIZING SOFT TISSUE CALCIFICATION
#187METHODS OF ADMINISTERING COMPOSITIONS INCLUDING IRON
#188Water-soluble iron carbohydrate derivative complexes, the preparation thereof, and medicaments comprising them
#189Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
#190Ferric organic compounds, uses thereof and methods of making same
#191Water-soluble binuclear nitrosyl iron complexes with natural aliphatic thiolyls possessing cytotoxic, apoptotic and no-donor activity
#192Method for producing purified hematinic iron-saccharadic complex and product produced
#193Iron(II)-Containing Treatments for Hyperphosphatemia
#194Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
#195Patches and method for the transdermal delivery of a therapeutically effective amount of iron
#196THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES
#197Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles
#198Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them
#199Phosphate binding materials and their uses
#200COBALT-AMINE BASED METAL COMPLEX AS AN ANTIBACTERIAL COMPOUND
#201Control of blood vessel physiology to treat skin disorders
#202Method of reversing, preventing, delaying or stabilizing soft tissue calcification
#203Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes
#204Method of Treating Chronic Kidney Disease
#205NITRATE AMINO ACID CHELATES
#206METHOD FOR MANUFACTURING METAL NANO PARTICLE SOLUTION
#207METHOD FOR REMOVING A MEDICAL DEVICE FROM A SPASMODIC CONSTRICTION IN A BODILY PASSAGEWAY
#208EXTERNAL PREPARATION FOR SKIN
#209Methods and Compositions for Enhancing Iron Absorption
#210Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
#211Method of screening for substances which proliferate natural killer cells
#212Method for proliferating natural killer cells
#213Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
#214Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)
#215Use of iron(III) complex compounds
#216METHODS OF USING ARTEMISININ-LIKE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER
#217COMPOUNDS FOR IMPROVING LEARNING AND MEMORY
#218PORPHYRIN OXYGEN INFUSION FOR INCREASING CONCENTRATIONS IN TUMOR TISSUES
#219Ruthenium complexes for treating cancers
#220Eggplant extract for medical treatments
#221Treatment for Necrotizing Enterocolitis
#222Use of nitric oxide adducts
#223Drug and method for proliferating natural killer cells
#224Use of pseudan and pseudan inclusion bodies
#225Methods of using redox-active surfactants to control polymer interactions
#226Enhanced occlusive effect photodynamic therapy
#227Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
#228Use of iron for treating attention deficit hyperactivity disorder in children
#229Compositions including iron
#230Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
#231Therapeutic delivery of carbon monoxide
#232Compositions and dosage forms for enhanced absorption
#233Iron complex
#234Organometallic anti-tumour agent
#235Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
#236Ferric organic compounds, uses thereof and methods of making same
#237Method for producing purified hematinic iron-saccharidic complex and product produced
#238Treatment of myopia
#239Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
#240Circuit for processing video signal including information such as caption
#241Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
#242Microdose therapy
#243Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
#244Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
#245Compositions and dosage forms for enhanced absorption
#246Administration of levodopa and carbidopa
#247Compositions and dosage forms for enhanced absorption of iron
#248Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
#249Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
#250Compositions and dosage forms for enhanced absorption of metformin
#251Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
#252Pharmaceutical compositions and their use in the treatment of neoplastic disease
#253Bioequivalence test for iron-containing formulations
#254As-needed administration of an androgenic agent to enhance female desire and responsiveness
#255Stable and bioavailable iron fortified beverages
#256Synthesis of high molecular weight iron-saccharidic complexes
#257Nitric oxide releasing compound, pharmaceutical composition, use and synthesis method thereof
#258Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
#259Nutritional supplements for treatment of iron deficiency anemia